LGC publishes ESG report for 2020-21

News (ZH) - LGC's first ESG report using GRI Standards, the most widely used sustainability reporting framework 

LGC reports half year trading in line with expectations

News (ZH) - Update for the half year ended 30 September 2021

LGC appoints Vivid Sehgal as Chief Financial Officer

News (ZH) - Replaces Simon Parsons, who will leave LGC after 11 years of service

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

News (ZH) - DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK